S
Salvatore Gattillo
Publications - 15
Citations - 433
Salvatore Gattillo is an academic researcher. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 6, co-authored 10 publications receiving 268 citations.
Papers
More filters
Journal ArticleDOI
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.
Sarah Marktel,Samantha Scaramuzza,Maria Pia Cicalese,Fabio Giglio,Stefania Galimberti,Maria Rosa Lidonnici,Valeria Calbi,Andrea Assanelli,Maria Ester Bernardo,Claudia Rossi,Andrea Calabria,Raffaella Milani,Salvatore Gattillo,Fabrizio Benedicenti,Giulio Spinozzi,Annamaria Aprile,Alessandra Bergami,Miriam Casiraghi,Giulia Consiglieri,Nicoletta Masera,Emanuela D'Angelo,Nadia Mirra,Raffaella Origa,Immacolata Tartaglione,Silverio Perrotta,Robert Winter,Milena Coppola,Gianluca Viarengo,Luca Santoleri,Giovanna Graziadei,Michela Gabaldo,Maria Grazia Valsecchi,Eugenio Montini,Luigi Naldini,Maria Domenica Cappellini,Fabio Ciceri,Alessandro Aiuti,Giuliana Ferrari +37 more
TL;DR: In a phase 1/2 clinical trial, gene therapy with autologous hematopoietic stem cells significantly reduced transfusion requirement in adults and children with transfusion dependent ß-thalassemia.
Journal ArticleDOI
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
Francesca Ferrua,Maria Pia Cicalese,Stefania Galimberti,Stefania Giannelli,Francesca Dionisio,Federica Barzaghi,Maddalena Migliavacca,Maria Ester Bernardo,Valeria Calbi,Andrea Assanelli,Marcella Facchini,Claudia Fossati,Elena Albertazzi,Samantha Scaramuzza,Immacolata Brigida,Serena Scala,Luca Basso-Ricci,Roberta Pajno,Miriam Casiraghi,Daniele Canarutto,Federica Andrea Salerio,Michael H. Albert,Antonella Bartoli,Hermann M. Wolf,Rossana Fiori,Paolo Silvani,Salvatore Gattillo,Anna Villa,Luca Biasco,Christopher Dott,Emily J. Culme-Seymour,Koenraad van Rossem,Gillian Atkinson,Maria Grazia Valsecchi,Maria Grazia Roncarolo,Fabio Ciceri,Luigi Naldini,Alessandro Aiuti +37 more
TL;DR: Overall survival was 100%.
Journal ArticleDOI
Wilms' Tumor Gene 1 Transcript Levels in Leukapheresis of Peripheral Blood Hematopoietic Cells Predict Relapse Risk in Patients Autografted for Acute Myeloid Leukemia
Carlo Messina,Anna Candoni,Matteo Carrabba,Cristina Tresoldi,Elisa Sala,M. Tassara,Alessandra Crippa,Jacopo Peccatori,Andrea Assanelli,Salvatore Gattillo,Laura Bellio,Renato Fanin,Fabio Ciceri,Massimo Bernardi +13 more
TL;DR: This study represents the largest series of patients evaluating WT1 as a marker of MRD in PBSC LK products using a completely standardized real-time WT1-reverse transcriptase-PCR based assay and established a correlation with clinical outcome.
Journal ArticleDOI
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress
Elisa Montaldo,Eleonora Lusito,Valentina Bianchessi,Nicoletta Caronni,Serena Scala,Luca Basso-Ricci,Carla Cantaffa,Alice Masserdotti,Mattia Barilaro,Simona Barresi,Marco Genua,F. M. Vittoria,Giulia Barbiera,Dejan Lazarevic,Carlo Messina,Elisabetta Xue,Sarah Marktel,Cristina Tresoldi,Raffaella Milani,Paola Ronchi,Salvatore Gattillo,Luca Santoleri,Raffaella Di Micco,Andrea Ditadi,Giulio Belfiori,Francesca Aleotti,Matteo M. Naldini,Bernhard Gentner,Elisa Gardiman,Nicola Tamassia,Marco A. Cassatella,Andrés Hidalgo,Immanuel Kwok,Lai Guan Ng,Stefano Crippa,Massimo Falconi,Francesca Pettinella,Patrizia Scapini,Luigi Naldini,Fabio Ciceri,Alessandro Aiuti,Renato Ostuni +41 more
TL;DR: Ostuni et al. as discussed by the authors performed immunophenotypic and transcriptome analysis to characterize the heterogeneity of human neutrophils, both under steady state and upon stress-induced conditions.
Journal ArticleDOI
Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation
Salvatore Gattillo,Sarah Marktel,Lorenzo Rizzo,Simona Malato,Lucia Malabarba,Milena Coppola,Andrea Assanelli,Raffaella Milani,Tiago De Freitas,Consuelo Corti,Laura Bellio,Fabio Ciceri +11 more
TL;DR: Plerixafor is a chemokine receptor CXC Type 4–stromal‐derived factor 1 inhibitor; its HSC‐mobilizing properties are synergistic with G‐CSF in poor mobilizing patients, and the use of PL as adjuvant or alternative to G‐ CSF in healthy donors has shown a good safety profile.